Texas Permanent School Fund Cytokinetics Inc Transaction History

Texas Permanent School Fund

$597 Billion
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$47.86 - $75.05 $243,463 - $381,779	-5,087 Reduced 5.93%	80,729 $4.37 Million
Q1 2024 May 03, 2024	BUY	$63.75 - $108.06 $70,826 - $120,054	1,111 Added 1.31%	85,816 $6.02 Million
Q4 2023 Feb 08, 2024	BUY	$26.88 - $83.49 $114,562 - $355,834	4,262 Added 5.3%	84,705 $7.07 Million
Q3 2023 Nov 09, 2023	SELL	$29.46 - $36.61 $50,553 - $62,822	-1,716 Reduced 2.09%	80,443 $2.37 Million
Q2 2023 Aug 07, 2023	SELL	$32.62 - $40.75 $125,358 - $156,602	-3,843 Reduced 4.47%	82,159 $2.68 Million
Q1 2023 May 01, 2023	BUY	$33.36 - $45.71 $708,766 - $971,154	21,246 Added 32.81%	86,002 $3.03 Million
Q4 2022 Feb 07, 2023	SELL	$35.77 - $51.11 $105,628 - $150,927	-2,953 Reduced 4.36%	64,756 $2.97 Million
Q3 2022 Oct 25, 2022	BUY	$38.54 - $54.52 $223,609 - $316,325	5,802 Added 9.37%	67,709 $3.28 Million
Q2 2022 Aug 08, 2022	BUY	$33.93 - $48.92 $82,721 - $119,266	2,438 Added 4.1%	61,907 $2.43 Million
Q1 2022 May 06, 2022	SELL	$29.74 - $46.0 $29,977 - $46,368	-1,008 Reduced 1.67%	59,469 $2.19 Million
Q4 2021 Feb 08, 2022	SELL	$34.35 - $46.38 $44,655 - $60,294	-1,300 Reduced 2.1%	60,477 $2.76 Million
Q3 2021 Oct 28, 2021	BUY	$18.54 - $35.74 $154,178 - $297,213	8,316 Added 15.56%	61,777 $2.21 Million
Q2 2021 Jul 27, 2021	BUY	$19.79 - $26.99 $6,609 - $9,014	334 Added 0.63%	53,461 $1.06 Million
Q1 2021 May 03, 2021	SELL	$18.57 - $25.68 $68,801 - $95,144	-3,705 Reduced 6.52%	53,127 $1.24 Million
Q4 2020 Feb 04, 2021	SELL	$15.26 - $28.61 $137,797 - $258,348	-9,030 Reduced 13.71%	56,832 $1.18 Million
Q3 2020 Nov 06, 2020	BUY	$20.58 - $28.96 $388,468 - $546,648	18,876 Added 40.17%	65,862 $1.43 Million
Q2 2020 Aug 04, 2020	SELL	$11.15 - $24.64 $36,795 - $81,312	-3,300 Reduced 6.56%	46,986 $1.11 Million
Q1 2020 Apr 27, 2020	BUY	$8.75 - $16.3 $86,388 - $160,929	9,873 Added 24.43%	50,286 $593,000
Q4 2019 Feb 03, 2020	BUY	$7.95 - $11.84 $3,768 - $5,612	474 Added 1.19%	40,413 $429,000
Q3 2019 Oct 31, 2019	BUY	$10.82 - $14.25 $8,277 - $10,901	765 Added 1.95%	39,939 $455,000
Q2 2019 Aug 09, 2019	BUY	$7.95 - $11.25 $16,106 - $22,792	2,026 Added 5.45%	39,174 $441,000
Q1 2019 May 02, 2019	BUY	$5.95 - $10.19 $8,008 - $13,715	1,346 Added 3.76%	37,148 $301,000
Q4 2018 Feb 11, 2019	BUY	$5.91 - $9.29 $8,451 - $13,284	1,430 Added 4.16%	35,802 $226,000
Q3 2018 Oct 22, 2018	BUY	$6.4 - $9.85 $9,548 - $14,696	1,492 Added 4.54%	34,372 $339,000
Q2 2018 Jul 23, 2018	SELL	$6.9 - $9.9 $4,505 - $6,464	-653 Reduced 1.95%	32,880 $273,000
Q1 2018 Apr 20, 2018	SELL	$7.2 - $10.05 $5,083 - $7,095	-706 Reduced 2.06%	33,533 $241,000
Q4 2017 Jan 23, 2018	SELL	$7.25 - $15.65 $18,777 - $40,533	-2,590 Reduced 7.03%	34,239 $279,000
Q3 2017 Nov 13, 2017	BUY	$12.0 - $15.0 $441,948 - $552,435	36,829	36,829 $534,000

Others Institutions Holding CYTK

# of Institutions

410

Shares Held

125M

Call Options Held

4.6M

Put Options Held

2.43M

Black Rock Inc. New York, NY

14.7M
Shares

$762 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$611 Million
0.01% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

9.69M
Shares

$503 Million
0.31% of portfolio
Wellington Management Group LLP Boston, MA

7.77M
Shares

$404 Million
0.07% of portfolio
State Street Corp Boston, MA

6.46M
Shares

$335 Million
0.01% of portfolio

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.89B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Permanent School Fund, based on Form 13F filings with the SEC.

News

Stay updated on Texas Permanent School Fund with notifications on news.

Account